BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34774484)

  • 1. N-glycosylation status of Trop2 impacts its surface density, interaction with claudin-7 and exosomal release.
    Kamble PR; Patkar SR; Breed AA; Pathak BR
    Arch Biochem Biophys; 2021 Dec; 714():109084. PubMed ID: 34774484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins.
    Wu CJ; Lu M; Feng X; Nakato G; Udey MC
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic cleavage of Trop2 at Arg87 is mediated by matriptase and regulated by Val194.
    Kamble PR; Rane S; Breed AA; Joseph S; Mahale SD; Pathak BR
    FEBS Lett; 2020 Oct; 594(19):3156-3169. PubMed ID: 32761920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPCAM and TROP2 share a role in claudin stabilization and development of intestinal and extraintestinal epithelia in mice.
    Szabo R; Ward JM; Artunc F; Bugge TH
    Biol Open; 2022 Jul; 11(7):. PubMed ID: 35730316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trop2 Forms a Stable Dimer with Significant Structural Differences within the Membrane-Distal Region as Compared to EpCAM.
    Pavšič M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
    Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM
    Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer.
    Jeon Y; Jo U; Hong J; Gong G; Lee HJ
    BMC Cancer; 2022 Sep; 22(1):1014. PubMed ID: 36153494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
    Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
    PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17.
    Wanger TM; Dewitt S; Collins A; Maitland NJ; Poghosyan Z; Knäuper V
    Cell Signal; 2015 Jul; 27(7):1325-35. PubMed ID: 25817572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
    Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
    Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.
    Philip R; Heiler S; Mu W; Büchler MW; Zöller M; Thuma F
    Oncotarget; 2015 Feb; 6(4):2046-63. PubMed ID: 25514462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer.
    Liu X; Deng J; Yuan Y; Chen W; Sun W; Wang Y; Huang H; Liang B; Ming T; Wen J; Huang B; Xing D
    Pharmacol Ther; 2022 Nov; 239():108296. PubMed ID: 36208791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
    Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
    Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
    Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
    Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trophoblast cell surface antigen 2 (Trop-2) phosphorylation by protein kinase C α/δ (PKCα/δ) enhances cell motility.
    Mori Y; Akita K; Ojima K; Iwamoto S; Yamashita T; Morii E; Nakada H
    J Biol Chem; 2019 Jul; 294(30):11513-11524. PubMed ID: 31177095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas?
    Akarken İ; Dere Y
    Ann Diagn Pathol; 2021 Feb; 50():151680. PubMed ID: 33341704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Trop2 in solid tumors: a look into structures and novel epitopes.
    Liu X; Li J; Deng J; Zhao J; Zhao G; Zhang T; Jiang H; Liang B; Xing D; Wang J
    Front Immunol; 2023; 14():1332489. PubMed ID: 38179054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis.
    Wu CJ; Feng X; Lu M; Morimura S; Udey MC
    J Clin Invest; 2017 Feb; 127(2):623-634. PubMed ID: 28094766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
    Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
    Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.